Metraipolis › archive › dc_026a79203efe

Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma — Europe PMC PMID:42352510

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42352510
DOI: 10.3390/cancers18121978
License (as archived): solo-consultazione
Archived: 2026-10-31T09:42:16.724Z
SHA-256 of the archived text: 98f6c1b58d6499013b1e0d9572d4bd715d2529db9da0216302334e9e88973840
Stable URL of this page: https://metraipolis.com/documento/dc_026a79203efe

How to cite

Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma — Europe PMC PMID:42352510 — Europe PMC (en), https://europepmc.org/article/MED/42352510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_026a79203efe (Metraipolis archive dc_026a79203efe, sha256 98f6c1b58d6499013b1e0d9572d4bd715d2529db9da0216302334e9e88973840)

BibTeX

@misc{dc026a79203efe,
  title = {Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma — Europe PMC PMID:42352510},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42352510},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_026a79203efe; sha256 98f6c1b58d6499013b1e0d9572d4bd715d2529db9da0216302334e9e88973840},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42352510. Agents can read the archived copy with the MCP tool read_document.